VRTX

NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$477.92

+19.11 (+4.17%)

As of Feb 12, 6:31 PM ET ·

VRTX News1 articles

Vertex Shares Surge on Analyst Upgrade, Pipeline Expansion in Focus

Vertex Pharmaceuticals shares climbed 5.7% following an upgrade from Oppenheimer, driven by its 2026 revenue outlook and expanding pipeline in gene-editing, pain, and kidney therapies.

Analysis 11h ago